esmolol has been researched along with Sepsis in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (14.81) | 29.6817 |
| 2010's | 16 (59.26) | 24.3611 |
| 2020's | 7 (25.93) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, C; Liu, Y; Yang, J; Yang, X; Yang, Y; Zhang, J | 1 |
| Gao, X; He, Z; Li, T; Wang, J; Xu, G | 1 |
| Cheng, Z; He, S; Ma, Y; Wang, W; Wei, C; Yang, J; Zheng, Y; Zhou, X | 1 |
| Guo, Y; Li, J; Li, Y; Ren, Y; Sun, W; Yang, Z | 1 |
| An, H; Guo, CA; Liu, HB; Ma, L; Su, XL; Wang, YZ; Zhang, B; Zhen, LL | 1 |
| Dong, S; He, X; Lu, Y; Wang, D; Wang, W; Yang, Y; Zhang, P | 1 |
| Feng, M; Liu, P; Tang, Y; Wu, Q; Zhou, Z | 1 |
| Chang, YT; Cheng, CC; Huang, MS; Huang, NC; Huang, WC; Hung, YM; Ke, MW; Tsai, JS; Wann, SR | 1 |
| Chen, F; Chen, ZQ; Zhu, JJ | 1 |
| Chen, L; Deng, Y; Li, X; Liu, X; Wen, M; Zeng, H; Zeng, J | 1 |
| Guarracino, F; Landoni, G; Morelli, A; Pappalardo, F; Pieri, M; Stefani, M; Zangrillo, A | 1 |
| Chen, JX; Jia, BH; Liu, YY; Sun, J | 1 |
| Friese, RS; Gomez, CT; Ibrahim-Zada, I; Rhee, P; Weller, J | 1 |
| Foex, P; Morelli, A; Sanfilippo, F; Santonocito, C | 1 |
| Guo, J; Nie, X; Wang, Z; Wu, Q; Yang, C | 2 |
| Rudiger, A; Singer, M | 1 |
| Bissell, BD; Ferreira, JA | 1 |
| Guomei, R; Hahn, RG; Li, Y; Qiannan, D; Xiaozhu, Z | 1 |
| Al-Azzawi, D; Crisostomo, PR; Lahm, T; Markel, TA; Meldrum, DR; Novotny, NM; Ray, R; Tan, J; Wang, M; Wang, Y | 1 |
| Rudiger, A | 1 |
| Ballarino, G; Gutierrez, G | 1 |
| Innami, Y; Ishikawa, A; Mori, K; Morisaki, H; Nakamura, N; Suzuki, T; Takeda, J; Yajima, S | 1 |
| Ishizaka, A; Kotake, Y; Morisaki, H; Serita, R; Suzuki, T; Takeda, J; Yamamoto, M | 1 |
| Meldrum, DR | 1 |
| Gore, DC; Wolfe, RR | 1 |
8 review(s) available for esmolol and Sepsis
| Article | Year |
|---|---|
Benefits of esmolol in adults with sepsis and septic shock: An updated meta-analysis of randomized controlled trials.
Topics: Adult; Humans; Propanolamines; Randomized Controlled Trials as Topic; Sepsis; Shock, Septic | 2022 |
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosphate; Adsorption; Adult; Africa, Eastern; Aged; Air Pollutants; Air Pollution; Air Pollution, Indoor; Alcohol Drinking; Allergens; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; Antibodies; Antibodies, Immobilized; Antigen Presentation; Antigens, CD; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Aptamers, Nucleotide; Asthma; Asthma, Exercise-Induced; Atrophy; Autophagy; Azoospermia; Bacillus cereus; Bacterial Infections; Beclin-1; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biofouling; Biological Monitoring; Biomarkers; Biomarkers, Tumor; Biosensing Techniques; Blastocyst; Bone Neoplasms; Bone Regeneration; Bronchoconstriction; Burkitt Lymphoma; C9orf72 Protein; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Cardiomyopathies; Caregivers; Carmine; Case-Control Studies; Catalysis; Cattle; Cause of Death; CCAAT-Enhancer-Binding Protein-alpha; CD8-Positive T-Lymphocytes; Cefepime; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Transdifferentiation; Chelating Agents; Chemical and Drug Induced Liver Injury, Chronic; Chemoradiotherapy, Adjuvant; Child; Child, Preschool; China; Chlorquinaldol; Cholangiocarcinoma; Cholera; Chromatin; Clinical Trials as Topic; Cognitive Dysfunction; Cohort Studies; Colonic Neoplasms; Colorectal Neoplasms; Colorimetry; Cooking; Coordination Complexes; COVID-19; Creatinine; CRISPR-Cas Systems; Critical Care; Critical Illness; Cross-Sectional Studies; Cryopreservation; Cryoprotective Agents; Cysteine; Cytokines; Device Removal; Diet; Diet, High-Fat; Diet, Mediterranean; Dietary Supplements; Dimethyl Sulfoxide; Dipeptides; Disease Models, Animal; Dithiothreitol; DNA; DNA Repeat Expansion; DNA, Bacterial; DNA, Complementary; Dopamine; Electrochemical Techniques; Electrodes; Endocannabinoids; Environmental Exposure; Environmental Monitoring; Environmental Pollutants; Enzyme-Linked Immunosorbent Assay; Erlotinib Hydrochloride; Escherichia coli; Escherichia coli O157; Esophageal Neoplasms; Esophagitis, Peptic; Ethylene Glycol; Europium; Exanthema; Fallopian Tubes; Feces; Female; Fertilization in Vitro; Fluoresceins; Fluorescent Dyes; Follicle Stimulating Hormone; Follow-Up Studies; Food Microbiology; Forced Expiratory Volume; Forkhead Transcription Factors; Frontotemporal Dementia; G-Quadruplexes; Galactose; Gastroenteritis; Gastrointestinal Diseases; Gastrointestinal Microbiome; Gastrointestinal Neoplasms; Gastrointestinal Tract; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genital Neoplasms, Female; Genome-Wide Association Study; Genome, Viral; Genomics; Genotype; Glucose; Glutathione; Glycerol; Gold; Graphite; GTPase-Activating Proteins; Heat-Shock Proteins; Heme Oxygenase-1; Hepacivirus; Hepatitis C; Hepatocytes; Histamine; Histocompatibility Antigens Class II; Hoarseness; Hospice and Palliative Care Nursing; Humans; Hydrogen; Hydrogen Peroxide; Hydrogen Sulfide; Hydroxybenzoates; Hydroxyl Radical; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperthermia, Induced; Hysteroscopy; Immunoassay; Indigo Carmine; Inflammation; Inflammatory Bowel Diseases; Insulin Resistance; Intensive Care Units; Interleukin-11; Interleukin-6; Interleukins; Iodine Radioisotopes; Iran; Iridium; Islets of Langerhans; Kinetics; Lactation; Lactobacillus; Lactobacillus plantarum; Lamins; Latin America; Lead; Lectins; Leukopenia; Ligands; Limit of Detection; Lipopolysaccharides; Lipoprotein Lipase; Liver; Liver Cirrhosis; Liver Neoplasms; Lolium; Luminescent Measurements; Luminol; Lung; Luteinizing Hormone; Macrophages; Magnetic Phenomena; Magnetic Resonance Imaging; Male; Malnutrition; Maltose; Manganese Compounds; Maternal Nutritional Physiological Phenomena; Melatonin; Metabolic Engineering; Metal Nanoparticles; Metallocenes; Metaplasia; Methicillin-Resistant Staphylococcus aureus; Methylation; Mevalonic Acid; Mexico; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microbial Sensitivity Tests; Microbiota; MicroRNAs; Milk; Mitomycin; Molecular Diagnostic Techniques; Molecular Docking Simulation; Monte Carlo Method; Moringa oleifera; Multiple Sclerosis; Muscle Strength; Muscle, Skeletal; Nanocomposites; Nanotubes, Carbon; Neoadjuvant Therapy; Neoplasms; Neurodegenerative Diseases; Neurotransmitter Agents; NF-E2-Related Factor 2; Nickel; Nitrogen Dioxide; Non-alcoholic Fatty Liver Disease; Nucleic Acid Amplification Techniques; Nucleic Acid Hybridization; Nucleocapsid Proteins; Nutritional Status; Obesity; Osteogenesis; Osteosarcoma; Oxidation-Reduction; Oxides; Oxygen; Oxyquinoline; Pain; Palliative Care; Pancreatic Neoplasms; Pandemics; Particulate Matter; Peroxidase; Peroxidases; Phagocytosis; Phaseolus; Photothermal Therapy; Point-of-Care Systems; Polyethyleneimine; Polymers; Polymorphism, Single Nucleotide; Polysomnography; Postoperative Complications; Pregnancy; Pregnant Women; Prenatal Exposure Delayed Effects; Prevalence; Printing, Three-Dimensional; Probability; Probiotics; Prognosis; Prophages; Prospective Studies; Proteomics; Proto-Oncogene Proteins; Pseudomonas aeruginosa; Pseudomonas putida; Pulmonary Disease, Chronic Obstructive; Pulmonary Embolism; Pyridines; Pyrroles; Quality of Life; Quinolones; Rabbits; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptors, Histamine; Receptors, Histamine H2; Recombinases; Rectal Neoplasms; Reperfusion Injury; Respiration; Respiratory Function Tests; Respiratory Rate; Respiratory Sounds; Retrospective Studies; rho GTP-Binding Proteins; Risk Assessment; Risk Factors; RNA; RNA, Messenger; RNA, Ribosomal, 16S; Robotic Surgical Procedures; Running; Rural Population; Saccharomyces cerevisiae; Salpingectomy; Sarcopenia; SARS-CoV-2; Seeds; Semen; Sensitivity and Specificity; Sepsis; Shock, Septic; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Skin Neoplasms; Sleep Apnea, Obstructive; Soil; Spain; Spectrum Analysis, Raman; Sperm Retrieval; Spermatozoa; Spirometry; Staphylococcus aureus; STAT3 Transcription Factor; Stereoisomerism; Sterilization, Tubal; Stroke Volume; Sulfadiazine; Sulfites; Superoxide Dismutase; Surface Plasmon Resonance; tau Proteins; Testis; Testosterone; Thioredoxin-Disulfide Reductase; Thyroid Neoplasms; Thyroidectomy; Trans-Activators; Transcription Factor AP-1; Treatment Outcome; Triazoles; Triclosan; Trifluridine; Tumor Microenvironment; Tumor Necrosis Factor-alpha; United States; Uracil; Vagina; Vegetables; Ventricular Function, Left; Ventricular Pressure; Vibrio cholerae; Vietnam; Virulence; Vital Capacity; Vitrification; Walking; Water; Water Pollutants, Radioactive; Whole Genome Sequencing; Wind; YAP-Signaling Proteins; Zeolites; Zinc Oxide | 2023 |
Prognosis of β-adrenergic blockade therapy on septic shock and sepsis: A systematic review and meta-analysis of randomized controlled studies.
Topics: Adrenergic beta-1 Receptor Antagonists; Catecholamines; Heart Failure; Hemodynamics; Humans; Prognosis; Propanolamines; Sepsis; Shock, Septic | 2020 |
The influence of esmolol on septic shock and sepsis: A meta-analysis of randomized controlled studies.
Topics: Adrenergic beta-1 Receptor Antagonists; Humans; Propanolamines; Randomized Controlled Trials as Topic; Sepsis; Shock, Septic; Treatment Outcome | 2018 |
Beta-blocker use in severe sepsis and septic shock: a systematic review.
Topics: Adrenergic beta-Antagonists; Animals; Heart Rate; Hemodynamics; Humans; Metoprolol; Propanolamines; Sepsis; Shock, Septic | 2015 |
Misdirected Sympathy: The Role of Sympatholysis in Sepsis and Septic Shock.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic beta-1 Receptor Antagonists; Animals; Catecholamines; Clonidine; Dexmedetomidine; Humans; Propanolamines; Sepsis; Shock, Septic; Stroke Volume; Sympathetic Nervous System; Sympatholytics; Tachycardia | 2018 |
beta-Blockers in sepsis: reexamining the evidence.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Animals; Cytokines; Endotoxins; Glucose; Hemodynamics; Humans; Hypertension; Inflammation; Lipopolysaccharides; Models, Biological; Myocardium; Propanolamines; Sepsis | 2009 |
Beta-block the septic heart.
Topics: Adrenergic beta-Antagonists; Animals; Cardiotonic Agents; Disease Models, Animal; Heart; Humans; Propanolamines; Propranolol; Rats; Sepsis; Systemic Inflammatory Response Syndrome | 2010 |
3 trial(s) available for esmolol and Sepsis
| Article | Year |
|---|---|
Evaluating the effects of Esmolol on cardiac function in patients with Septic cardiomyopathy by Speck-tracking echocardiography-a randomized controlled trial.
Topics: Cardiomyopathies; Echocardiography; Humans; Prospective Studies; Sepsis; Shock, Septic; Stroke Volume; Ventricular Function, Left | 2023 |
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosphate; Adsorption; Adult; Africa, Eastern; Aged; Air Pollutants; Air Pollution; Air Pollution, Indoor; Alcohol Drinking; Allergens; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; Antibodies; Antibodies, Immobilized; Antigen Presentation; Antigens, CD; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Aptamers, Nucleotide; Asthma; Asthma, Exercise-Induced; Atrophy; Autophagy; Azoospermia; Bacillus cereus; Bacterial Infections; Beclin-1; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biofouling; Biological Monitoring; Biomarkers; Biomarkers, Tumor; Biosensing Techniques; Blastocyst; Bone Neoplasms; Bone Regeneration; Bronchoconstriction; Burkitt Lymphoma; C9orf72 Protein; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Cardiomyopathies; Caregivers; Carmine; Case-Control Studies; Catalysis; Cattle; Cause of Death; CCAAT-Enhancer-Binding Protein-alpha; CD8-Positive T-Lymphocytes; Cefepime; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Transdifferentiation; Chelating Agents; Chemical and Drug Induced Liver Injury, Chronic; Chemoradiotherapy, Adjuvant; Child; Child, Preschool; China; Chlorquinaldol; Cholangiocarcinoma; Cholera; Chromatin; Clinical Trials as Topic; Cognitive Dysfunction; Cohort Studies; Colonic Neoplasms; Colorectal Neoplasms; Colorimetry; Cooking; Coordination Complexes; COVID-19; Creatinine; CRISPR-Cas Systems; Critical Care; Critical Illness; Cross-Sectional Studies; Cryopreservation; Cryoprotective Agents; Cysteine; Cytokines; Device Removal; Diet; Diet, High-Fat; Diet, Mediterranean; Dietary Supplements; Dimethyl Sulfoxide; Dipeptides; Disease Models, Animal; Dithiothreitol; DNA; DNA Repeat Expansion; DNA, Bacterial; DNA, Complementary; Dopamine; Electrochemical Techniques; Electrodes; Endocannabinoids; Environmental Exposure; Environmental Monitoring; Environmental Pollutants; Enzyme-Linked Immunosorbent Assay; Erlotinib Hydrochloride; Escherichia coli; Escherichia coli O157; Esophageal Neoplasms; Esophagitis, Peptic; Ethylene Glycol; Europium; Exanthema; Fallopian Tubes; Feces; Female; Fertilization in Vitro; Fluoresceins; Fluorescent Dyes; Follicle Stimulating Hormone; Follow-Up Studies; Food Microbiology; Forced Expiratory Volume; Forkhead Transcription Factors; Frontotemporal Dementia; G-Quadruplexes; Galactose; Gastroenteritis; Gastrointestinal Diseases; Gastrointestinal Microbiome; Gastrointestinal Neoplasms; Gastrointestinal Tract; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genital Neoplasms, Female; Genome-Wide Association Study; Genome, Viral; Genomics; Genotype; Glucose; Glutathione; Glycerol; Gold; Graphite; GTPase-Activating Proteins; Heat-Shock Proteins; Heme Oxygenase-1; Hepacivirus; Hepatitis C; Hepatocytes; Histamine; Histocompatibility Antigens Class II; Hoarseness; Hospice and Palliative Care Nursing; Humans; Hydrogen; Hydrogen Peroxide; Hydrogen Sulfide; Hydroxybenzoates; Hydroxyl Radical; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperthermia, Induced; Hysteroscopy; Immunoassay; Indigo Carmine; Inflammation; Inflammatory Bowel Diseases; Insulin Resistance; Intensive Care Units; Interleukin-11; Interleukin-6; Interleukins; Iodine Radioisotopes; Iran; Iridium; Islets of Langerhans; Kinetics; Lactation; Lactobacillus; Lactobacillus plantarum; Lamins; Latin America; Lead; Lectins; Leukopenia; Ligands; Limit of Detection; Lipopolysaccharides; Lipoprotein Lipase; Liver; Liver Cirrhosis; Liver Neoplasms; Lolium; Luminescent Measurements; Luminol; Lung; Luteinizing Hormone; Macrophages; Magnetic Phenomena; Magnetic Resonance Imaging; Male; Malnutrition; Maltose; Manganese Compounds; Maternal Nutritional Physiological Phenomena; Melatonin; Metabolic Engineering; Metal Nanoparticles; Metallocenes; Metaplasia; Methicillin-Resistant Staphylococcus aureus; Methylation; Mevalonic Acid; Mexico; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microbial Sensitivity Tests; Microbiota; MicroRNAs; Milk; Mitomycin; Molecular Diagnostic Techniques; Molecular Docking Simulation; Monte Carlo Method; Moringa oleifera; Multiple Sclerosis; Muscle Strength; Muscle, Skeletal; Nanocomposites; Nanotubes, Carbon; Neoadjuvant Therapy; Neoplasms; Neurodegenerative Diseases; Neurotransmitter Agents; NF-E2-Related Factor 2; Nickel; Nitrogen Dioxide; Non-alcoholic Fatty Liver Disease; Nucleic Acid Amplification Techniques; Nucleic Acid Hybridization; Nucleocapsid Proteins; Nutritional Status; Obesity; Osteogenesis; Osteosarcoma; Oxidation-Reduction; Oxides; Oxygen; Oxyquinoline; Pain; Palliative Care; Pancreatic Neoplasms; Pandemics; Particulate Matter; Peroxidase; Peroxidases; Phagocytosis; Phaseolus; Photothermal Therapy; Point-of-Care Systems; Polyethyleneimine; Polymers; Polymorphism, Single Nucleotide; Polysomnography; Postoperative Complications; Pregnancy; Pregnant Women; Prenatal Exposure Delayed Effects; Prevalence; Printing, Three-Dimensional; Probability; Probiotics; Prognosis; Prophages; Prospective Studies; Proteomics; Proto-Oncogene Proteins; Pseudomonas aeruginosa; Pseudomonas putida; Pulmonary Disease, Chronic Obstructive; Pulmonary Embolism; Pyridines; Pyrroles; Quality of Life; Quinolones; Rabbits; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptors, Histamine; Receptors, Histamine H2; Recombinases; Rectal Neoplasms; Reperfusion Injury; Respiration; Respiratory Function Tests; Respiratory Rate; Respiratory Sounds; Retrospective Studies; rho GTP-Binding Proteins; Risk Assessment; Risk Factors; RNA; RNA, Messenger; RNA, Ribosomal, 16S; Robotic Surgical Procedures; Running; Rural Population; Saccharomyces cerevisiae; Salpingectomy; Sarcopenia; SARS-CoV-2; Seeds; Semen; Sensitivity and Specificity; Sepsis; Shock, Septic; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Skin Neoplasms; Sleep Apnea, Obstructive; Soil; Spain; Spectrum Analysis, Raman; Sperm Retrieval; Spermatozoa; Spirometry; Staphylococcus aureus; STAT3 Transcription Factor; Stereoisomerism; Sterilization, Tubal; Stroke Volume; Sulfadiazine; Sulfites; Superoxide Dismutase; Surface Plasmon Resonance; tau Proteins; Testis; Testosterone; Thioredoxin-Disulfide Reductase; Thyroid Neoplasms; Thyroidectomy; Trans-Activators; Transcription Factor AP-1; Treatment Outcome; Triazoles; Triclosan; Trifluridine; Tumor Microenvironment; Tumor Necrosis Factor-alpha; United States; Uracil; Vagina; Vegetables; Ventricular Function, Left; Ventricular Pressure; Vibrio cholerae; Vietnam; Virulence; Vital Capacity; Vitrification; Walking; Water; Water Pollutants, Radioactive; Whole Genome Sequencing; Wind; YAP-Signaling Proteins; Zeolites; Zinc Oxide | 2023 |
Combination therapy with milrinone and esmolol for heart protection in patients with severe sepsis: a prospective, randomized trial.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Cardiotonic Agents; Drug Therapy, Combination; Female; Heart; Heart Rate; Humans; Male; Middle Aged; Milrinone; Propanolamines; Prospective Studies; Protective Agents; Sepsis | 2015 |
17 other study(ies) available for esmolol and Sepsis
| Article | Year |
|---|---|
LOW DOSE OF ESMOLOL ATTENUATES SEPSIS-INDUCED IMMUNOSUPPRESSION VIA MODULATING T-LYMPHOCYTE APOPTOSIS AND DIFFERENTIATION.
Topics: Animals; Apoptosis; Caspase 3; CD4-Positive T-Lymphocytes; Cell Differentiation; Hypotension; Immunosuppression Therapy; Leukocytes, Mononuclear; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; Sepsis; Shock, Septic | 2023 |
Esmolol inhibits inflammation and apoptosis in the intestinal tissue via the overexpression of NF-κB-p65 in the early stage sepsis rats.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Blotting, Western; Disease Models, Animal; Inflammation; Intestinal Mucosa; Propanolamines; Rats; Sepsis; Survival Analysis; Transcription Factor RelA | 2020 |
Esmolol reduces apoptosis and inflammation in early sepsis rats with abdominal infection.
Topics: Abdomen; Adrenergic beta-1 Receptor Antagonists; Animals; Anti-Bacterial Agents; Apoptosis; bcl-2-Associated X Protein; Disease Models, Animal; HMGB1 Protein; Inflammation Mediators; Interleukin-6; Male; Propanolamines; Proto-Oncogene Proteins c-bcl-2; Rats; Sepsis; Surgical Wound Infection; Tumor Necrosis Factor-alpha | 2017 |
Effects of epinephrine on heart rate variability and cytokines in a rat sepsis model.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-1 Receptor Antagonists; Animals; Cytokines; Disease Models, Animal; Epinephrine; Heart Rate; Male; Propanolamines; Propranolol; Rats; Rats, Sprague-Dawley; Sepsis | 2020 |
Letter to the Editor Regarding Article, "Esmolol reduces apoptosis and inflammation in early sepsis rats with abdominal infection".
Topics: Animals; Apoptosis; Inflammation; Propanolamines; Rats; Sepsis | 2019 |
[β1 receptor blocker decreases the myocardial inflammation in the sepsis adult rats through inhibition of TLR4/NF-ΚB signaling pathway].
Topics: Animals; Inflammation; Interleukin-1beta; Male; Myocardium; NF-kappa B; Propanolamines; Rats; Rats, Wistar; Sepsis; Signal Transduction; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2019 |
Esmolol administration in patients with VV ECMO: why not?
Topics: Acute Lung Injury; Adrenergic beta-Antagonists; Blood Pressure; Contraindications; Extracorporeal Membrane Oxygenation; Heart Rate; Humans; Hypoxia; Positive-Pressure Respiration; Propanolamines; Sepsis | 2013 |
[Effects of adrenergic beta-1 antagonists on hemodynamics of severe septic patients].
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Cardiac Output; Female; Hemodynamics; Humans; Male; Middle Aged; Propanolamines; Sepsis | 2013 |
Inhibition of sepsis-induced inflammatory response by β1-adrenergic antagonists.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; BRCA1 Protein; Disease Models, Animal; Gene Expression Regulation; Kaplan-Meier Estimate; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Microarray Analysis; Molecular Biology; NF-kappa B p50 Subunit; Propanolamines; Random Allocation; Real-Time Polymerase Chain Reaction; Reference Values; RNA; Sepsis; Survival Analysis; Systemic Inflammatory Response Syndrome | 2014 |
Infusion of esmolol attenuates lipopolysaccharide-induced myocardial dysfunction.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Apoptosis; Blotting, Western; Cardiomyopathies; In Situ Nick-End Labeling; Infusions, Parenteral; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Propanolamines; Random Allocation; Sepsis; Ventricular Function, Left | 2016 |
Decatecholaminisation during sepsis.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Adrenergic beta-1 Receptor Antagonists; Catecholamines; Dexmedetomidine; Humans; Norepinephrine; Propanolamines; Sepsis | 2016 |
Effects of vasoactive drugs on crystalloid fluid kinetics in septic sheep.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Cardiotonic Agents; Crystalloid Solutions; Dopamine; Hemodynamics; Isotonic Solutions; Male; Norepinephrine; Phenylephrine; Propanolamines; Ringer's Lactate; Sepsis; Sheep; Sodium Chloride; Vasoconstrictor Agents | 2017 |
Gut mucosal permeability, β1 receptor blockers and gastric tonometry: the time is now!
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Intestinal Mucosa; Male; Permeability; Propanolamines; Sepsis | 2011 |
Beta-1 blocker improves survival of septic rats through preservation of gut barrier function.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Inflammation; Intestinal Mucosa; Male; Permeability; Propanolamines; Random Allocation; Rats; Rats, Wistar; Sepsis; Tumor Necrosis Factor-alpha | 2011 |
Infusion of the beta-adrenergic blocker esmolol attenuates myocardial dysfunction in septic rats.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Cardiomyopathies; Cardiotonic Agents; Cytokines; Disease Models, Animal; Hemodynamics; Infusions, Intravenous; Male; Myocardium; Oxygen Consumption; Propanolamines; Rats; Rats, Wistar; Sepsis | 2005 |
Beta-blockade during sepsis: inspired or insane?
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Cardiac Output; Cardiomyopathies; Cardiotonic Agents; Humans; Male; Myocardium; Oxygen Consumption; Propanolamines; Rats; Sepsis | 2005 |
Hemodynamic and metabolic effects of selective beta1 adrenergic blockade during sepsis.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Adult; APACHE; Body Surface Area; Calorimetry, Indirect; Cardiac Output; Creatinine; Heart Rate; Hemodynamics; Hemoglobins; Humans; Lung Compliance; Middle Aged; Oxygen; Propanolamines; Sepsis | 2006 |